Mogrify Company
Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.
Investors
Technology:
AgeTech Companies, Cell therapy
Industry:
Healthcare, Private
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2019-01-01
Employees Number:
101-250
Funding Status:
Early Stage Venture
Investors Number:
8
Total Funding:
37800000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-09-03
Last Funding Type:
Series A
Register and Claim Ownership